Clinicopathological Variables Predicting Progression of Azotemia in Cats with Chronic Kidney Disease

Journal of Veterinary Internal Medicine

Volumn 26, Issue 2, 2012, Pages 275-281

  Chakrabarti, S ^a   Syme, H M ^a   Elliott, J ^a  

^a ROYAL VETERINARY COLLEGE   (United Kingdom)

Author keywords

Anemia; Hyperphosphatemia; Nephrology; Proteinuria

Indexed keywords

BIOLOGICAL MARKER; CREATININE; PHOSPHATE;

ANIMAL; ANIMAL DISEASE; ARTICLE; BLOOD; CAT; CAT DISEASE; CHRONIC KIDNEY FAILURE; DISEASE COURSE; FEMALE; LONGITUDINAL STUDY; MALE; PATHOLOGY; STATISTICAL MODEL; UREMIA;

ANIMALS; AZOTEMIA; BIOLOGICAL MARKERS; CAT DISEASES; CATS; CREATININE; DISEASE PROGRESSION; FEMALE; KIDNEY FAILURE, CHRONIC; LOGISTIC MODELS; LONGITUDINAL STUDIES; MALE; PHOSPHATES;

ANIMALIA;

EID: 84858753367     PISSN: 08916640     EISSN: 19391676     Source Type: Journal    
DOI: 10.1111/j.1939-1676.2011.00874.x     Document Type: Article

References (25)

1. Syme HM, Markwell PJ, Pfeiffer D, et al. Survival of cats with naturally occurring chronic renal failure is related to severity of proteinuria. J Vet Intern Med 2006;20:528-535.
2. King JN, Tasker S, Gunn-Moore DA, et al. Prognostic factors in cats with chronic kidney disease. J Vet Intern Med 2007;21:906-916.
3. Kuwahara Y, Ohba Y, Kitoh K, et al. Association of laboratory data and death within one month in cats with chronic renal failure. J Small Anim Pract 2006;47:446-450.
4. Boyd LM, Langston C, Thompson K, et al. Survival in cats with naturally occurring chronic kidney disease (2000-2002). J Vet Intern Med 2008;22:1111-1117.
5. Elliott J, Rawlings JM, Markwell PJ, et al. Survival of cats with naturally occurring chronic renal failure: Effect of dietary management. J Small Anim Pract 2000;41:235-242.
6. Ross SJ, Osborne CA, Kirk CA, et al. Clinical evaluation of dietary modification for treatment of spontaneous chronic kidney disease in cats. J Am Vet Med Assoc 2006;229:949-957.
7. Elliott J, Elliott D. Dietary therapy for feline chronic kidney disease. In: Pascale P, Biourge V, Elliott D, eds. Encyclopedia of Feline Clinical Nutrition. Aimargues: Aniwa SAS Ltd; 2008:411-445.
8. Adams LG, Polzin DJ, Osborne CA, et al. Influence of dietary protein/calorie intake on renal morphology and function in cats with 5/6 nephrectomy. Lab Invest 1994;70:347-357.
9. Ross LA, Finco DR, Crowell WA. Effect of dietary phosphorus restriction on the kidneys of cats with reduced renal mass. Am J Vet Res 1982;43:1023-1026.
10. Jepson RE, Brodbelt D, Vallance C, et al. Evaluation of predictors of the development of azotemia in cats. J Vet Intern Med 2009;23:806-813.
11. King JN, Gunn-Moore DA, Tasker S, et al. Tolerability and efficacy of benazepril in cats with chronic kidney disease. J Vet Intern Med 2006;20:1054-1064.
12. Mizutani H, Koyama H, Watanabe T, et al. Evaluation of the clinical efficacy of benazepril in the treatment of chronic renal insufficiency in cats. J Vet Intern Med 2006;20:1074-1079.
13. Nakajima H, Takenaka M, Kaimori JY, et al. Gene expression profile of renal proximal tubules regulated by proteinuria. Kidney Int 2002;61:1577-1587.
14. Eddy AA. Interstitial nephritis induced by protein-overload proteinuria. Am J Pathol 1989;135:719-733.
15. Takei T, Otsubo S, Uchida K, et al. Effects of sevelamer on the progression of vascular calcification in patients on chronic haemodialysis. Nephron Clin Pract 2008;108:c278-283.
16. Chiu YW, Adler S, Budoff M, et al. Prevalence and prognostic significance of renal artery calcification in patients with diabetes and proteinuria. Clin J Am Soc Nephrol 2010;5:2093-2100.
17. Pechereau D, Martel P, Braun JP. Plasma erythropoietin concentrations in dogs and cats: Reference values and changes with anaemia and/or chronic renal failure. Res Vet Sci 1997;62:185-188.
18. Bachmann S, Le Hir M, Eckardt KU. Co-localization of erythropoietin mRNA and ecto-5′-nucleotidase immunoreactivity in peritubular cells of rat renal cortex indicates that fibroblasts produce erythropoietin. J Histochem Cytochem 1993;41:335-341.
19. Furth SL, Cole SR, Fadrowski JJ, et al. The association of anemia and hypoalbuminemia with accelerated decline in GFR among adolescents with chronic kidney disease. Pediatr Nephrol 2007;22:265-271.
20. Thorp ML, Johnson ES, Yang X, et al. Effect of anaemia on mortality, cardiovascular hospitalizations and end-stage renal disease among patients with chronic kidney disease. Nephrology (Carlton) 2009;14:240-246.
21. Tapolyai M, Kadomatsu S, Perera-Chong M. r.hu-erythropoietin (EPO) treatment of pre-ESRD patients slows the rate of progression of renal decline. BMC Nephrol 2003;4:3.
22. Gouva C, Nikolopoulos P, Ioannidis JP, et al. Treating anemia early in renal failure patients slows the decline of renal function: A randomized controlled trial. Kidney Int 2004;66:753-760.
23. Rossert J, McClellan WM, Roger SD, et al. Epoetin treatment: What are the arguments to expect a beneficial effect on renal disease progression? Nephrol Dial Transplant 2002;17:359-362.
24. Cowgill LD, James KM, Levy JK, et al. Use of recombinant human erythropoietin for management of anemia in dogs and cats with renal failure. J Am Vet Med Assoc 1998;212:521-528.
25. Randolph JE, Scarlett JM, Stokol T, et al. Expression, bioactivity, and clinical assessment of recombinant feline erythropoietin. Am J Vet Res 2004;65:1355-1366.